Uridine diphosphate N-acetylglucosamine
| Names | |
|---|---|
| IUPAC name
Uridine 5′-(2-acetamido-2-deoxy-α-D-glucopyranosyl dihydrogen diphosphate) | |
| Systematic IUPAC name
O1-[(2R,3R,4R,5S,6R)-3-Acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl] O3-{[(2R,3S,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-3,4-dihydroxyoxolan-2-yl]methyl} dihydrogen diphosphate | |
| Other names
UDP-N-acetylglucosamine; UDP-GlcNAc | |
| Identifiers | |
3D model (JSmol) |
|
PubChem CID |
|
CompTox Dashboard (EPA) |
|
| |
| Properties | |
| C17H27N3O17P2 | |
| Molar mass | 607.355 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
Infobox references | |
Uridine diphosphate N-acetylglucosamine or UDP-GlcNAc is a nucleotide sugar and a coenzyme in metabolism. It is used by glycosyltransferases to transfer N-acetylglucosamine residues to substrates. UDP-GlcNAc is used for making glycosaminoglycans, proteoglycans, and glycolipids. D-Glucosamine is made naturally in the form of glucosamine-6-phosphate, and is the biochemical precursor of all nitrogen-containing sugars. To be specific, glucosamine-6-phosphate is synthesized from fructose 6-phosphate and glutamine as the first step of the hexosamine biosynthesis pathway. The end-product of this pathway is UDP-GlcNAc. Some enzymes involved in the biosynthesis of UDP-GlcNAc vary between prokaryotic and eukaryotic organisms, serving as potential drug targets for antibiotic development.